Firdapse for Post-BOTOX Vocal Weakness

Clinical trial NCT05123053 · COMPLETED

Trial details

NCT number: NCT05123053
Sponsor: Augusta University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Vocal Weakness(Post-BOTOX Injection)

Start date: 2021-10-28
Primary completion: 2025-05-27
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.